Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict
Stock Price and Recent Performance Pfizer’s stock has struggled in 2025, hovering near multi-year lows. At ~$23.60 per share in late September, PFE has declined about 9% since January, underperforming the S&P